Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 4Paraproteinemias 1Neoplasms, Plasma Cell 1Lymphoproliferative Disorders 1Lymphoma, Non-Hodgkin 1Leukemia 1

Interventions

Tacrolimus 4Epoetin Alfa 4Busulfan 4fludarabine 3Darbepoetin alfa 3Bortezomib 3fludarabine phosphate 2dacetuzumab 2Rituximab 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Lenalidomide 2Early Intervention, Educational 2Dexamethasone 2Antilymphocyte Serum 2Alemtuzumab 2venetoclax 1trametinib 1ruxolitinib 1plerixafor 1isatuximab 1ficlatuzumab 1ferrous sulfate 1ferric gluconate 1ethanolamine oleate 1dabrafenib 1Vorinostat 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Tinzaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoproliferative Disorders × Chromatin Immunoprecipitation Sequencing × Plasma cell × Clear all
NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Mayo Clinic

Phase NA Recruiting
82 enrolled
LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡